John Doux
Director at Palvella Therapeutics, Inc. (PVLA) since April 2026
John Doux has filed 3 insider reports with the SEC since April 2026, as director at Palvella Therapeutics, Inc. (PVLA). The latest filing, on June 12, 2026, reports grant or award at Palvella Therapeutics, Inc. (PVLA).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where John Doux is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince April 2026 | $144.35 | Jun 12, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 10, 2026PVLASEC Form 4 filed by Director Doux JohnForm 4Grant or award
- Apr 13, 2026PVLAJohn Doux became an insiderForm 3New insider
- Apr 13, 2026PVLASEC Form 4 filed by Doux JohnForm 4Grant or award
Compare John Doux with
- John Doux vs Jeffrey S Martini1 shared
- John Doux vs Kathleen Goin1 shared
- John Doux vs George M Jenkins1 shared
- John Doux vs Christopher P Kiritsy1 shared
- John Doux vs Matthew Pauls1 shared
- John Doux vs Matthew E Korenberg1 shared
Other insiders at the same companies
- Jeffrey S MartiniPVLA
- Kathleen GoinPVLA
- George M JenkinsPVLA
- Christopher P KiritsyPVLA
- Matthew PaulsPVLA
- Matthew E KorenbergPVLA
- Elaine J HeronPVLA
- Todd C DavisPVLA
- Tadd S. WesselPVLA
- Ashley Hartmann KlinePVLA
- Wes KaupinenPVLA
- Palvella Therapeutics, Inc.PVLA
- Bvf Partners L P/ilPVLA
- Dellora Investments LPPVLA
- James A GeraghtyPVLA
Questions about John Doux
- What is John Doux's role at Palvella Therapeutics, Inc.?
- John Doux reports to the SEC as director at Palvella Therapeutics, Inc. (PVLA), according to the latest filing on June 12, 2026.
- Has John Doux bought or sold stock recently?
- No open-market purchases or sales by John Doux are on file. The filings report grant or award.
- How do I get alerts when John Doux files?
- Follow John Doux on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by John Doux (SEC CIK 0001912574). Totals count each trade once, skipping amendments whose original is on file, from Apr 15, 2026 on. View on SEC EDGAR